Dr. Jeff Lombardo, PharmD, BCOP, Research Assistant Professor, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
discusses chemotherapy compounding, related safety issues, and the advantages of INFUGEM™ (gemcitabine hydrochloride in 0.9% sodium chloride injection).
Associate Director
Empire State Patient Safety Assurance Network
Center for Integrated Global Biomedical Sciences
Research Assistant Professor
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo, New York
Related Items
JHOP - June 2025 Vol 15, No 3 published on June 11, 2025 in Practical Issues in Pharmacy Management, Leukemia
JHOP - June 2024 Vol 14, No 3 published on May 23, 2024 in Practical Issues in Pharmacy Management, Oncology Pharmacy Programs/Protocols, Breast Cancer, CDK4/6 Inhibitors, Adverse Events
JHOP - October 2023 Vol 13, No 5 published on October 9, 2023 in Practical Issues in Pharmacy Management, Oncology Pharmacy Programs/Protocols, Oral Therapy, Chemotherapy, Supportive Care